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Major depression is the second leading cause of global disability in
the world and the eleventh leading cause of global burden.1
Although a number of effective treatments are currently available,
fewer than half of people with depression worldwide receive
adequate care.2 Among barriers to treatment, stigma and
discrimination related to mental disorders play a crucial role.3
Mental ill health discrimination is universally experienced and
influences many aspects of people’s lives: it represents a barrier
to social integration, it limits life opportunities and has a negative
impact on help-seeking behaviour; it produces changes in feelings
and attitudes for both patients (lower self-esteem, poorer self-care
and social withdrawal) and their family members (feelings of guilt,
shame, despair).4 Although the literature shows that participants
in studies across the world express largely similar types of
expectations and experiences of mental ill health discrimination,
some cultural specificities do exist.5,6 Empirical evidence
demonstrates differences in symptom expression and understanding
of illness, and cultural influences have been noted in care-seeking
and public acceptance of the illness.7,8 However, findings from
studies in different cultural contexts are difficult to compare, since
research in this field has been conducted by using inconsistent
and/or heterogeneous methodologies. Moreover, a considerable
amount of information comes from research conducted among
ethnic minorities living in Western countries, such as the USA9–11
or the UK,12 rather than on populations living in their own
countries. In addition, cross-cultural research has mainly
addressed stigma related to schizophrenia13,14 or mental disorders
in general,15,16 rather than depression specifically. Still, a few
studies have shown that this latter condition has better public
acceptance than schizophrenia;6,17,18 it could therefore be expected
that some specificities in depression-related stigma may exist.
Further, cross-cultural research in this field has generally focused
on attitudes of the general population towards mental disorders or
people with mental disorders,10,16,19,20 rather than on the ways in
which behavioural consequences of stigma (discrimination) are
experienced by people with depression.21 Finally, the few existing
cross-national comparative studies on stigma and discrimination
related to depression have been carried out in Western countries
only.22–24 To fill these knowledge gaps, the present explanatory
study was undertaken and aims, for people with major depressive
disorder (MDD), to (a) compare reported discrimination across
different countries in the world; and (b) explore the relative




Data were collected within the frame of the European Union
(EU)-funded ASPEN (Anti Stigma Programme European
Network) study, which was nested within the larger INDIGO-
Depression (International Study of Discrimination and Stigma
for Depression) research network. Full details of the ASPEN/
INDIGO-depression study are given elsewhere.25 Overall, 40 sites
in 34 countries worldwide were included (Africa: Egypt, Morocco,
Nigeria (4 sites), Tunisia; America: Brazil, Canada, Venezuela;
Asia: India, Japan, Malaysia, Pakistan, Sri Lanka, Taiwan; Europe:
Belgium, Bulgaria, Croatia, Czech Republic, Finland, France,
Germany, Greece, Hungary, Italy (2 sites), Lithuania, The
Netherlands, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain,
Turkey, UK (2 sites); Oceania: Australia).
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Background
No study has so far explored differences in discrimination
reported by people with major depressive disorder (MDD)
across countries and cultures.
Aims
To (a) compare reported discrimination across different
countries, and (b) explore the relative weight of individual
and contextual factors in explaining levels of reported
discrimination in people with MDD.
Method
Cross-sectional multisite international survey (34 countries
worldwide) of 1082 people with MDD. Experienced and
anticipated discrimination were assessed by the
Discrimination and Stigma Scale (DISC). Countries were
classified according to their rating on the Human
Development Index (HDI). Multilevel negative binomial and
Poisson models were used.
Results
People living in ‘very high HDI’ countries reported higher
discrimination than those in ‘medium/low HDI’ countries.
Variation in reported discrimination across countries was
only partially explained by individual-level variables. The
contribution of country-level variables was significant for
anticipated discrimination only.
Conclusions
Contextual factors play an important role in anticipated
discrimination. Country-specific interventions should be
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Participants
This was intentionally a pragmatic study25 in which many low-
and middle-income countries were included who participated
using only locally available resources as no external grant
provision was available. Within centres, site directors were asked
to identify a minimum of 25 participants who were, in their
judgement, reasonably representative (as a group) of all people
with a diagnosis of MDD attending specialist mental health
services (either out-patient or day care in both the public and
private sectors in the local area). The minimum number of 25
for each site was defined for feasibility issues, particularly for
non-European sites with no grant support. This method, used
in our previous schizophrenia study,26 was intended to allow local
staff to take into account the specific local service configuration
and to draw participants from the whole range of appropriate
local services. Staff at each site ensured that the sample had a
spread across the adult age range (young people (18–25 years),
working years (25–65) and older adults (565)) and a clear
representation of female participants as MDD is twice as prevalent
in women as men. Inclusion criteria were: (a) clinical diagnosis of
MDD (single episode or recurrent) according to DSM-IV-TR27
criteria during the previous 12 months (diagnosis had been made
by patients’ treating clinicians at the time of treatment contact and
was not reassessed at the time of study recruitment); (b) written
informed consent to participate; (c) ability to understand and
speak the main local language; and (d) aged 18 or older. Exclusion
criteria were: (a) being a psychiatric in-patient at time of recruit-
ment; and (b) having a comorbid diagnosis of schizophrenia
(other comorbidities were accepted). The ASPEN/INDIGO-
depression study was approved by the appropriate ethical review
board at each study site.
Measures
Participants were assessed face-to-face by independent researchers
not involved in the care process using the Discrimination and
Stigma Scale (version 12; DISC-12)28 – a structured mix-method
interview for recording the discrimination experienced by an
individual with a mental disorder. Full details of the psychometric
properties of this scale are reported elsewhere.28 DISC-12 asks 32
questions about aspects of everyday life including work, marriage,
parenting, housing, leisure and religious activities. Items 1–21 are
to ascertain experienced discrimination (for example ‘Have you
been treated unfairly in making or keeping friends?’); items 22–
25, anticipated discrimination (for example ‘Have you stopped
yourself from applying for work?’); items 26 and 27, positive
treatment (for example, ‘Have you been treated more positively
by your family?’); and items 28–32, coping strategies to overcome
discrimination (for example ‘Have you been able to use your
personal skills or abilities in copingwith stigma and discrimination?’).
Participants’ responses were rated with a four-point Likert scale
(0, no difference; 1, a little different; 2, moderately different;
and 3, a lot different). The DISC-12 items were divided into
four subscales – experienced discrimination (0–21), anticipated
discrimination (0–4), overcome discrimination and positive
treatment. Only the first two subscales will be addressed here.
For each subscale a total score is generated by counting the
number of items in which participants score 1, 2 or 3. DISC-12
also allows qualitative information to be gathered to add detail
to the experiences rated, providing a strong validation for the
occurrence, direction and severity of the discrimination rated
quantitatively, which is not discussed in this report but will
be reported on elsewhere. Sociodemographic and clinical
information (years since first contact with mental health services,
type of mental healthcare, lifetime number of depressive episodes,
admission to psychiatric hospital, advantage of having received a
diagnosis of MDD as an explanation for one’s own mental health
problems) are also recorded.
Stratification of ASPEN/INDIGO study sites
The ASPEN/INDIGO-depression countries were grouped using
the Human Development Index (HDI),29 a summary measure of
human development produced by the United Nations (for this
study we used 2010 data).29 The HDI measures the average
achievements of a country in three basic dimensions of human
development: (a) a long and healthy life; (b) access to knowledge;
(c) a decent standard of living. The three dimensions are
measured by: (a) life expectancy at birth (data source: UNDESA
United Nations Department of Economic and Social Affairs
2009); (b) mean years of schooling (data sources: population
censuses and household survey data compiled by UNESCO,
EUROSTAT and others) and expected years of schooling (data
source: UNESCO Institute for Statistics 2010); (c) gross national
income per capita (data source: World Bank 2010 and Inter-
national Monetary Fund 2010).29 Countries are ranked by
their HDI rating. HDI classification is based on quartiles and
denoted as ‘very high’, ‘high’, ‘medium’ and ‘low’. ASPEN/INDIGO-
depression participating countries were grouped as follows:
‘very high HDI’ (Australia, The Netherlands, Canada, Germany,
Japan, France, Finland, Belgium, Spain, Greece, Italy, UK, Czech
Republic, Slovenia, Slovakia, Hungary, Portugal), ‘high HDI’
(Lithuania, Romania, Croatia, Malaysia, Bulgaria, Serbia, Brazil,
Venezuela, Tunisia, Turkey) and ‘medium/low HDI’ (Sri Lanka,
Egypt, Morocco, India, Nigeria, Pakistan, Taiwan). The categories
‘medium’ and ‘low’ were put together as Nigeria was the only ‘low
HDI’ country.
Statistical analysis
Analyses were performed using Stata 13.0 for Windows. All
P-values were two-tailed with an accepted significance level of
0.05. Categorical variables were presented as percentages, and
continuous variables were presented as mean values with standard
deviations. Comparisons among independent groups were
performed by chi-squared and Kruskal–Wallis tests respectively.
As a result of the data dependencies induced by the nesting of
patients (level 1) within countries (level 2), multilevel models were
used, which allowed the simultaneous examination of the effects
of individual-level and country-level variables on individual-level
outcomes. More specifically, given the distribution of data,
negative binomial (‘menbreg’ command) was suitable for
‘experienced discrimination’ subscore and poisson (‘mepoisson’
command) for ‘anticipated discrimination’ subscore.
The steps in the construction of the models were: (a) study
differences in reported discrimination among countries (M0: a
multilevel model with the country effects modelled as random
or intercept only model); (b) include individual variables (M1:
experienced or anticipated discrimination subscore, age, gender,
marital status, working condition, education, advantage to have
an MDD diagnosis as an explanation for one’s own mental health
problems, lifetime number of depressive episodes, out-patient
mental healthcare, admission to psychiatric hospital) as fixed
effects (‘years since first contact with mental health services’ was
not included because it was significantly associated with ‘lifetime
number of episodes of major depression’); and (c) include human
development classification for country level (M2: M1+HDI).
Cross-level interactions terms were added where appropriate.
The multivariate models M1 and M2 were estimated, intro-
ducing as patients’ characteristics only those variables that were
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found significantly associated (P50.05) with the dependent
variable in the univariate multilevel models. The proportional
change in variance estimates of the different models was
calculated. This indicates the part that patients’ characteristics
and countries’ HDI classification, respectively, explain concerning
the total inter-country variation.
Results
Overall, 1087 people with MDD worldwide participated in the
study. Participants’ characteristics stratified by the three HDI
country groupings are shown in Table 1. Country groups differed
for all the sociodemographics considered (with exception of
gender composition), with participants from the ‘medium/low
HDI’ group showing lower mean age, lower educational level,
higher unpaid work rate and lower retired rate. Moreover, country
groups differed for almost all the clinical characteristics
considered (with the exception of out-patient mental healthcare
and advantage to have an MDD diagnosis), with participants from
the ‘medium/low HDI’ group showing lower contact duration
with mental health services, lower number of depressive episodes
and lower hospital admission rates.
Average scores for experienced discrimination by HDI group
were 3.97 (s.d. = 3.50) for the ‘very high’, 3.38 (s.d. = 3.34) for
the ‘high’ and 3.30 (s.d. = 3.74) for the ‘medium/low’ group
(Fig. 1 ). Average scores for anticipated discrimination by HDI
group were 1.68 (s.d. = 1.12) for the ‘very high’, 1.56 (s.d. = 1.13)
for the ‘high’ and 1.24 (s.d. = 1.08) for the ‘medium/low’ group
(Fig. 2). The comparison of average scores among the three
country groupings revealed significant between-group variation
for both experienced (Kruskal–Wallis, P50.001) and anticipated
(Kurskal–Wallis, P50.001) discrimination.
Table 2 shows the comparison of the percentage of parti-
cipants that endorsed experienced discrimination and anticipated
discrimination in the various DISC-12 items among the three
country groupings. Experiences of discrimination were more
frequent in participants living in ‘very high HDI’ countries than
in ‘medium/low HDI’ countries; this difference reached statistical
significance in most life domains, such as making or keeping
friends, family, finding a job, welfare benefits, physical health,
mental health staff and parental role (chi-squared, P50.05). It
should also be noted that the percentage of people reporting to
have been shunned or avoided by others is 1.6-fold higher in ‘very
high HDI’ countries than in ‘medium/low HDI’ countries, which
is a highly significant difference (chi-squared, P50.001). Only
religious practices showed a reverse pattern, with a higher
percentage of discrimination reported in the ‘medium/low HDI’
group. Participants of ‘very high HDI’ countries also reported
more anticipated discrimination than those living in the other two
country groups for all the DISC-12 domains (chi-squared, P50.05).
Table 3 shows fixed and random parameters estimated from
multilevel negative binomial models for experienced discrim-
ination. A significant variation across countries was found (model
M0, country-level variability not explained by other variables:
0.13, likelihood ratio test P50.001). When individual-level
variables were included (model M1), anticipated discrimination,
sociodemographics (age; widowed/separated/divorced marital
status; unpaid work, unemployment or student) and clinical
characteristics (previous admissions for psychiatric treatment;
number of episodes of depression) were statistically significant
and random variation between countries decreased by 30.8% (thus
indicating that nearly a third of country-level variation came from
differences in the population composition in each country).
Stratification of countries according to HDI (model M2) was not
statistically significant and consequently the between-countries
variation did not change.
Table 4 shows fixed and random parameters estimated from
multilevel Poisson models for anticipated discrimination. A
significant variation across countries was found (model M0,
likelihood ratio test P50.001). When individual-level variables
were included (model M1), experienced discrimination, age and
single/non-cohabiting partner marital status were statistically
significant and random variation between countries decreased by
37.5%. When country stratification according to the HDI was
added (model M2), the between-countries variation decreased to
62.5% (thus indicating that 25% of the country-level variation
came from differences in human development). No significant
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Table 1 Sociodemographic and illness-related characteristics of the overall sample stratified by country groups (very high Human






(n = 270) Pa
Male, % 34.0 30.3 38.5 0.110
Age, years: mean (s.d.) 47.2 (15.3) 45.3 (14.6) 39.8 (14.0) 50.001
Lower education, % 44.1 35.1 55.0 50.001
Marital status, %
Married/cohabiting 44.4 51.6 59.0 0.001
Single 30.5 24.0 26.1
Widowed/separated/divorced 25.1 24.4 14.9
Employment,b %
Full time/part time 39.2 39.9 40.5 50.001
Volunteer/sheltered/at home 4.4 8.6 22.7
Unemployed/student 36.5 33.9 31.5
Retired 19.9 17.6 5.3
Years since first mental health contact, mean (s.d.) 11.7 (12.2) 9.2 (9.4) 6.4 (8.7) 50.001
Out-patient mental healthcare, % 87.2 82.6 84.3 0.185
Advantage to have a diagnosis of major depressive disorder
as an explanation for one’s own mental health problems, % 80.8 79.0 78.6 0.737
Lifetime depressive episodes 56, % 41.4 30.0 25.0 50.001
Ever psychiatric admission, % 41.2 42.4 27.2 50.001
a. Chi-squared for percentages and Kruskal–Wallis for means (s.d.s).
b. The original 11 categories were collapsed by distinguishing participants who: work and are paid, work but are not paid, do not work, and are retired.
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Table 2 Comparison of percentages of participants with major depressive disorder reporting discriminationa in the various
Discrimination and Stigma Scale (DISC-12) items by country groups (very high Human Development Index (HDI), high HDI,
medium/low HDI)















Experienced discrimination (n= 1082)
Making or keeping friends 41.1 6.2 30.4 7.3 27.8 1.9 50.001
Neighbourhood 17.2 29.6 23.2 12.7 17.8 1.5 0.116
Dating or intimate relationships 32.5 29.6 27.3 59.6 28.0 18.9 0.348
Housing 13.2 36.2 14.0 35.7 13.9 17.0 0.953
Education 22.7 44.3 18.6 44.6 19.5 25.6 0.511
Marriage or divorce 38.9 35.4 30.6 28.3 31.2 23.7 0.081
Family 44.4 2.4 43.8 1.9 30.0 0.7 50.001
Finding a job 27.5 46.1 23.8 45.9 16.5 29.6 0.022
Keeping a job 34.5 29.8 31.1 32.8 26.0 36.7 0.150
Public transport 7.7 21.9 6.4 24.5 8.8 11.1 0.607
Welfare benefits or disability pensions 27.8 50.1 18.0 48.1 9.4 67.8 0.001
Religious practices 7.2 39.0 2.7 27.1 10.1 4.4 0.005
Social life 23.1 9.9 17.0 18.8 19.7 1.5 0.149
Police 11.1 40.4 5.4 28.7 9.6 22.6 0.073
Physical health problems 23.1 6.6 15.1 4.1 11.8 2.6 50.001
Mental health staff 26.0 3.6 16.8 1.0 12.5 1.5 50.001
Personal privacy 14.3 3.4 20.7 5.4 19.4 2.2 0.044
Personal safety and security 24.2 7.6 19.6 1.9 21.9 1.5 0.323
Starting a family or having children 16.8 59.4 17.0 50.6 12.7 32.6 0.446
Role as a parent 26.5 46.1 18.4 35.4 14.2 28.9 0.004
Avoided or shunned by people 40.7 2.2 34.1 5.1 25.4 1.5 50.001
Anticipated discrimination (n= 1080)b
Applying for a job 48.2 38.6 40.6 35.0 27.2 27.4 50.001
Applying for education or training 35.2 33.0 33.7 35.7 23.3 33.0 0.019
Close personal relationship 47.5 10.5 43.2 10.8 30.4 11.5 50.001
Concealed or hidden mental health
problems 77.7 0.8 69.0 0.6 62.4 1.1 50.001
a. The figure was obtained by combining discrimination categories 1, 2, 3 for each item. If patients had never had the opportunity to experience an aspect of life or an activity,
a not applicable response was recorded.








































































































































































































Fig. 1 Experienced discrimination scores by countries within groups with (a) very high, (b) high and (c) medium/low Human Development
Index (n = 1082).


































































































































































































Fig. 2 Anticipated discrimination scores by countries within groups with (a) very high, (b) high and (c) medium/low Human Development
Index (n = 1080).
Anticipated discrimination: number of items (range 0–4) in which participants reported a disadvantage. Czech R., Czech Republic.
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Table 3 Multilevel negative binomial regression models for experienced discrimination (overall sample n = 1082)a
M0: variance components M1: M0 + patient-level characteristics M2: M1 + country-level characteristics
Estimate (s.e.) P Estimate (s.e.) P Estimate (s.e.) P
Fixed effects
Intercept 1.25 (0.07) 50.001 0.88 (0.16) 50.001 0.90 (0.18) 50.001
Patient-level characteristics
Anticipated discrimination 0.29 (0.03) 50.001 0.29 (0.03) 50.001
Age 70.01 (0.00) 0.001 70.01 (0.00) 0.001
Advantage to have a diagnosis of major
depressive disorder
0.07 (0.08) 0.399 0.06 (0.08) 0.405
Ever admitted for psychiatric treatment 0.32 (0.07) 50.001 0.32 (0.07) 50.001
Six or more lifetime episodes
of depression
0.23 (0.07) 0.001 0.23 (0.07) 0.001
Marital status
Married or co-habiting Reference Reference
Single or no co-habiting partner 0.01 (0.08) 0.970 0.01 (0.08) 0.984
Widowed, separated or divorced 0.16 (0.08) 0.043 0.17 (0.08) 0.042
Low education
(up to secondary 416 years)
70.08 (0.07) 0.255 70.08 (0.07) 0.230
Working condition
Full time or part time Reference Reference
Volunteer, sheltered or at home 0.26 (0.11) 0.020 0.26 (0.11) 0.021
Unemployed or a student 0.14 (0.07) 0.048 0.14 (0.07) 0.048
Retired 70.10 (0.12) 0.410 70.10 (0.12) 0.420
Country-level characteristics, Human
Development Index (HDI)
Very high HDI Reference
High HDI 70.10 (0.15) 0.531
Medium/low HDI 0.01 (0.17) 0.941
Random-effect variances
Country-level 0.13 (0.04) – 0.09 (0.03) – 0.09 (0.03) –
Proportion reduction in variance estimates
compared with intercept only model, % 30.8 30.8
Likelihood ratio test 87.44 50.001 42.07 50.001 37.81 50.001
a. Only independent variables significantly associated (P50.05) with the dependent variable in the univariable models were introduced in the multivariable models.
Table 4 Multilevel poisson regression models for anticipated discrimination (overall sample n = 1080)a
M0: variance components M1: M0 + patient-level characteristics M2: M1 + country-level characteristics
Estimate (s.e.) P Estimate (s.e.) P Estimate (s.e.) P
Fixed effects
Intercept 0.39 (0.06) 50.001 0.30 (0.15) 0.043 0.42 (0.16) 0.008
Patient-level characteristics
Experienced discrimination 0.06 (0.01) 50.001 0.06 (0.01) 50.001
Age 70.01 (0.00) 0.052 70.01 (0.00) 0.052
Advantage to have a diagnosis of major
depressive disorder
0.07 (0.07) 0.356 0.07 (0.07) 0.374
Six or more lifetime episodes
of depression
0.09 (0.07) 0.167 0.08 (0.07) 0.256
Marital status
Married or co-habiting Reference Reference
Single or no co-habiting partner 0.16 (0.08) 0.040 0.15 (0.08) 0.054
Widowed, separated or divorced 0.01 (0.08) 0.911 70.01 (0.08) 0.994
Working condition
Full time or part time Reference Reference
Volunteer, sheltered or at home 70.13 (0.11) 0.267 70.08 (0.12) 0.473
Unemployed or a student 0.01 (0.07) 0.976 0.01 (0.07) 0.989
Retired 70.16 (0.12) 0.201 70.16 (0.12) 0.187
Country-level characteristics, Human
Development Index (HDI)
Very high HDI Reference
High HDI 70.06 (0.11) 0.605
Medium/low HDI 70.34 (0.13) 0.007
Random-effect variances
Country level 0.08 (0.03) – 0.05 (0.02) – 0.03 (0.02) –
Proportion reduction in variance
estimates compared with intercept only
model, % 37.5 62.5
Likelihood ratio test 88.45 50.001 21.86 50.001 13.30 50.001
a. Only independent variables significantly associated (P50.05) with the dependent variable in the univariable models were introduced in the multivariable models.
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cross-level interaction was found between the significant
individual-level experienced discrimination subscore and the
country-level HDI classification.
Discussion
Reported discrimination among people with MDD is more severe
in high-income countries. Multilevel regression models showed
that this association was not significant for experienced
discrimination, but significant for anticipated discrimination.
This finding seems robust since the variation between countries
decreased by 62.5% after adjusting for individual- and country-
level variables and 25% of this decrease was explained by the
HDI. The finding that anticipated discrimination differs across
countries in parallel to their level of human development (with
higher discrimination in the higher-income countries) deserves
an in-depth conceptual analysis. In the DISC-12 anticipated
discrimination occurs when a person limits their own involvement
in important aspects of everyday life because of the expectation of
being discriminated against (for example, when an individual does
not apply for a job because he/she fully expects to fail in any such
application). Therefore, respondents scoring high on the
anticipated discrimination items not only anticipate discrim-
ination, they also decided to give up and not pursue their goals
– this is referred to as the ‘why-try’ effect.30 Thus, our findings
indicate that anticipated discrimination has concrete consequences
and a real impact on people’s lives with more severe effect for
those living in high-income countries.
Interpretation of findings
It therefore seems that the context (as a reflection of social norms
and values that are typical of a given sociocultural group) matters
in facilitating or hindering people with MDD to involve
themselves in a number of important life activities. Other reasons
for more anticipated discrimination in high-income countries
may include the nature of employment, the broader socio-
economic context and the explanatory models of mental disorders
and self-attribution. In this study almost twice as many patients
living in high-income countries anticipated discrimination in
the job domain, compared with those living in lower- and
middle-income countries. The process of seeking entry (or re-entry)
into the job market for anyone with a substantial disruption in
work record in highly industrialised societies is typically frustrating
and disheartening, and can be traumatic for recovering patients.31,32
In contrast, in traditional societies when patients recover from
their symptoms, they are far more likely to find work and often
find it much easier to reassume the work roles they had before.33
Further, in industrialised societies, the work environment is
typically impersonal and can be intensely competitive. Thus, even
when a person recovering from a severe episode of major
depression finds a job, the profound sense of marginality and
insecurity lingers on. Work relationships in industrialised
countries are under more bureaucratic regimentation; this is less
likely to be the case for patients living in traditional societies,
since their work roles are more integrated with other aspects of
their lives and are less likely to be taken away simply because
of questions about their performance.
Another possible reason for lower levels of anticipated
discrimination in low-income countries is the nature of
community support. Most developing societies are based on
collectivistic values,34 with primary emphasis on social relations
and a range of conventions, rules and roles that tend to sustain
long-term relationships and make isolation unusual even for
people who are the most disabled. In contrast, in industrialised
countries (where the social structure is generally individualistic)
relationships are more likely to be bilaterally defined, contractual
in nature and subject to constant re-evaluation and revocation.35
It is thus plausible that the intense individualism characteristic of
some Western societies might not be conducive to recovery from
mental ill health. Along with their emphasis on independence,
self-reliance and personal freedom, individualistic value
orientations also tend to foster fierce competition, frequent life
changes and alienation, and they do not usually provide the kind
of structured, stable and predictable environments that allow
people with mental health conditions to recuperate at their own
pace and to be reintegrated into society. There is initial empirical
evidence that social context may make the difference for people
with depression to perceive the ‘others’ as more or less supportive
and/or stigmatising, since some recent studies found that greater
community support and social capital are associated with less
perceived discrimination.36,37
Explanatory models of mental disorders and self-attribution
may also play a relevant role in shaping the perception of
discrimination by people with depression. Traditional societies
in low-income countries offer cultural belief systems that generally
externalise causality of psychiatric problems (for example God’s
will, Karma or other supernatural entities),7,38 thus lessening
individual and family blame. In contrast, in most high-income
industrialised countries the prevailing paradigm is based on the
biomedical model where mental disorders are assumed to have a
biological basis.39 The notion that mental disorders are simply
‘brain diseases’ that exist as such in nature has proved to be
extremely damaging to those with mental ill health. This notion
is responsible for unwarranted and destructive pessimism about
the chances of recovery, and has ignored what is actually going
on in these people’s lives, in their families and in the societies they
live in.40 This results in stigmatisation and rejection from the
outside, and self-attribution and self-blame from the inside. This
is in contrast to low-income countries where expectations of
severe mental disorders are that these conditions are like any other
acute illness and societal reactions are in keeping with this view.41
In relation to the difference between high- and medium-/low-
income countries being particularly evident for anticipated
discrimination, this may be because of a stronger and more visible
service-user movement in some high-income countries campaigning
on issues of discrimination, which has raised awareness among
those with mental health problems of the discrimination they
may experience. This is supported by a growing body of research
detailing the nature and extent of discrimination across a range
of settings.4 As service-user groups/movements emerge in low-
income countries, it may be that people with mental health
problems in these countries will also become more aware of the
discrimination they may experience.
Strengths and limitations
This study has the following strengths. The use of interviews to
gather direct self-reports from people with depression, both of
discrimination that was actually experienced (rather than
hypothetical scenarios or vignettes) and that which was
anticipated. Most research on discrimination and depression has
largely been descriptive, concerning surveys of public attitudes
about hypothetical situations rather than how discrimination is
experienced by people with MDD. Moreover, collection of self-
report on discrimination may empower service users by giving
them a voice and acknowledge the validity of their experience.
This study also has several limitations. Samples sizes in the
participating countries were relatively small. Participants were
selected from treated patients rather than from people with
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MDD living in the community, thus limiting the generalisability
of results to all people with MDD living in participating sites.
Selection bias could have occurred as participants were recruited
on the basis of access to mental health services, the judgement
of local research staff and their willingness to participate. More-
over, because of the relatively low sample size in the participating
countries, we could not control for possible contextual differences
within a given country (for example rural v. urban, deprived v.
affluent areas). Disability and clinical severity measures were
not used, therefore it was not easy to understand how far
discrimination reported by respondents was more realistically
attributable to disorder-related impairments or to negative
appraisal of life circumstances influenced by current levels of
depressive symptoms; this issue warrants further investigation.
The cross-sectional study design does not provide evidence of
causal relationships between putative predictors and levels of
discrimination, nor about the time that it takes for stigma to
develop and have consequences. The nature of this study was
explanatory and therefore no a priori hypothesis was formulated
about the direction of possible associations between cross-cultural
differences and discrimination. No information was gathered on
other possible minority statuses; this could have been a potential
source of bias in case of patients with multiple minority statuses
(for example ethnic, religious, sexual, physical illness). Finally,
social desirability is a common limitation of self-report stigma
measures that may vary cross-culturally.
Implications for future research
Overall, the results of this study suggest that close personal
relationships and informal social support networks may play a
significant role in buffering anticipated discrimination in people
with depression; therefore the ‘social distance’ element of stigma
is an important focus for future research. This also implies that
culturally sensitive measures of social capital should be included
in future cross-cultural research on stigma and discrimination.
Moreover, we need more high-quality qualitative research in
this field to gain a more in-depth insight about how
discrimination really has an impact on peoples’ lives and studies
that will allow relating these reported/perceived findings to the
outcome of mental disorders and the impact on people’s lives.
Longitudinal studies indicating how and when stigma develops
and how stigma and its consequences change over time would also
be very useful.
A tentative agenda for future interventions
The majority of people in high-income countries tend to attribute
major depression to neurobiological causes.18 The percentage of
the general public endorsing this view has steadily increased over
the past 15 years, in parallel with the spread of the message
launched by some campaigns worldwide claiming that mental
illness is ‘a disease like any other’. However, social distance and
perceived danger associated with people with depression has not
decreased significantly over the same period in Western Europe42
and the USA.43 Holding a neurobiological conception of mental
disorders seems to increase the likelihood of support for
treatment, but it is not associated with reduced stigmatisation
beliefs; a neurobiological understanding of mental disorders
seems to be rather associated with an increase of community
rejection.18,39 The assumption underlying a number of anti-stigma
campaigns launched over the past decades in high-income
countries (i.e. educating people about the biological basis of
mental disorders automatically leads to an improvement in their
attitudes towards those with mental illness) therefore appears
questionable. Because the public holds a tacit understanding of
the aetiology of mental illness, our efforts need to move past this
message.43 Reconfiguring stigma reduction strategies in high-
income countries may require providers and advocates to shift
to an emphasis on competence and inclusion. Efforts should
prioritise inclusion, integration, competences for the reduction
of cultural barriers to recognition, response and recovery. Unless
we tackle stigma at the cultural level, the prospects for changing
the lives of those affected by mental disorders will be unlikely to
happen.
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